No segmentation disclosed for this filer. n/a
Synovics Pharmaceuticals, Inc. booked $26.0M in FY2008 revenue, growing 11% year over year — about the middle of the pack among Healthcare companies we track, at a -15.4% net margin.
No filings loaded — no CIK (non-SEC filer).